Tweenvest Stocks

Alps Group Inc (NasdaqGM: ALPS)

Health Care · Biotechnology · MY

$0.34

-8.11% today · -97.2% 1Y

Alps Group Inc (NasdaqGM: ALPS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $56.58M and employs 93 people.

Over the last twelve months the share price has lost 97.2%, trading between 0.23 and 12.01.

Tweenvest scores Alps Group Inc across four factors: quality 40/100, value 52/100. Its strongest factor is value.

ALPS price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$56.58M
Revenue (TTM)
$3.74M
P/E
—
EPS
-0.05
Dividend yield
—
Beta (5Y)
-0.11
52-week high
$12.01
52-week low
$0.23
Avg volume (3M)
—
Shares outstanding
166.40M
Employees
93
Next earnings
—

About Alps Group Inc

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

ISIN
KYG0231P1081
Listed since
Oct 31, 2025
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
Biosino Bio-Technology and Science IncorporationSEHK: 8247$57.71MHK$3.13-0.32%
B&K Corporation LimitedSEHK: 2396$57.42MHK$3.83-8.70%
Caribou Biosciences, Inc.NasdaqGS: CRBU$57.12M$0.53-4.86%
Anti-Microbial Savior BioteQ Co., Ltd.TPEX: 6864$56.85MNT$48.70-2.60%
Xilio Therapeutics, Inc.NasdaqCM: XLO$56.26M$8.55-5.52%
Boundless Bio, Inc.NasdaqGS: BOLD$55.27M$2.43+5.19%
Synthaverse S.A.WSE: SVE$55.01Mzł2.81-0.88%
Gain Therapeutics, Inc.NasdaqGM: GANX$54.99M$1.26-23.17%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.